CCSG support of research nurses and clinical research associates dedicated to the conduct and completion ofinnovative, feasibility or proof-of-principle clinical trials proposed by Cancer Center Programs is critical forSJCRH's continued contribution to pediatric oncology. The Cancer Center leadership is dedicated to protocolspecificresearch and only trials considered to be of the highest priority are supported by this resource. Ourcommitment to protocol-based research is illustrated in Summary Table 3 in section 7.0 of this grantapplication. That table shows that for the index year of October 1, 2005 through September 30, 2006, of 373patients presenting to St. Jude, 247 (66%) were treated on a therapeutic clinical trial as part of their initialtreatment at St. Jude. Eighty-five (85%) of these enrollments were Cancer Center protocols, with theremaining 15% on industry or national protocols. In addition, of the 247 patients enrolling on therapeutic trialsduring the index year, 56 (23%) were also treated on more than one trial, resulting in 312 therapeuticenrollments. This is largely a result of St. Jude's concentrated effort to recruit previously treated patients to St.Jude for our Phase l/ll Developmental Therapeutics Program. Finally, the 373 patients presenting during theindex year also contributed to 549 non-therapeutic enrollments, for a total of 861 protocol enrollments duringthe index year.
Showing the most recent 10 out of 6764 publications
